PROSTAGLANDINS EXCRETION IN PREECLAMPSIA NIH GUIDE, Volume 22, Number 5, February 5, 1993 RFP AVAILABLE: NICHD-DESPR-93-02 P.T. 34 Keywords: Prostaglandins Pregnancy National Institute of Child Health and Human Development The National Institute of Child Health and Human Development (NICHD) is planning a study to determine whether or not urinary excretion of prostaglandin metabolites is altered in preeclamptic patients before the clinical onset of disease, and to determine the effect of oral calcium supplementation during pregnancy on the excretion of these metabolites. This will be a nested case control study using stored urine specimens collected at specified times during pregnancy from pregnant women participating in the NICHD Trial of Calcium for Preeclampsia Prevention (CPEP). This trial, which recently has been initiated by the NICHD at five universities across the country, is a randomized clinical trial designed to determine whether or not oral calcium supplementation will prevent preeclampsia. The contractor will be expected to measure metabolites of prostacyclin and thromboxane in approximately 700 urine specimens selected by the Project Officer over the course of two years. The NICHD expects to make one award from this solicitation. This announcement is a new solicitation. The issuance of this Request for Proposals (RFP) will be on or about February 19, 1993, and proposals are due by 4:00 p.m. (local time), April 16, 1993. A short-form version of the RFP will be provided first. This includes the Statement of Work, Technical Reporting Requirements, Background Information, and the Evaluation Criteria to be used for selection of the awardee. After examining this, a full-text version of the RFP must be requested, in writing, for those organizations interested in responding. INQUIRIES Organizations desiring a copy of the short-form RFP may send their written request to: Mrs. Lynn Salo Office of Grants and Contracts National Institute of Child Health and Human Development 6100 Building, Room 7A07 Bethesda, MD 20892 FAX: (301) 402-3676 FAX requests are acceptable. All requests must cite the RFP number NICHD-DESPR-93-02 and include two self-addressed mailing labels. All sources that consider themselves qualified are encouraged to submit a proposal. This advertisement does not commit the government to make an award. .
Return to NIH Guide Main Index
Office of Extramural Research (OER) |
National Institutes of Health (NIH) 9000 Rockville Pike Bethesda, Maryland 20892 |
Department of Health and Human Services (HHS) |
||||||||
Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files. |